Results 41 to 50 of about 5,486 (237)
Use of Midodrine in Heart Failure: Two Case Reports and a Review of the Literature
Hypotension in patients with heart failure is much more frequent in daily clinical practice than the 10–15% reported in clinical trials. In patients with heart failure with reduced ejection fraction (HFrEF), hypotension frequently limits the initiation ...
Adnan Hajjiah +6 more
doaj +1 more source
Vasovagal syncope (VVS) can occur in every third of human population. Clinical symptoms of VVS areas a result of arterial hypotension with critical global cerebral hypoperfusion due to vasodilatation and bradicardia.
A. V. Pevzner +3 more
doaj +1 more source
Pharmacological Treatment of Postprandial Reductions in Blood Pressure : A Systematic Review [PDF]
Funded by The Dunhill Medical Trust.
Alam +28 more
core +1 more source
Clinical Prognostic Factors in Pediatric Patients With Orthostatic Intolerance
Midodrine is widely used for orthostatic intolerance (OI); however, little is known about the prognostic factors of OI after midodrine treatment. We retrospectively reviewed electronic medical charts to investigate clinical prognostic factors of OI on ...
Kazue Ishitsuka MD, MPH, PhD +5 more
doaj +1 more source
Lymphoma Induced Chylothorax Complicated by Disseminated Histoplasmosis and Esophagopericardial Fistula. [PDF]
ABSTRACT This case report highlights the need to consider both infection and malignancy in the differential of a chylothorax, particularly in an immunosuppressed patient. The case demonstrates the challenges in treating a chylothorax, both in terms of appropriate drainage and the necessity to maintain a low‐fat diet.
Liu B +4 more
europepmc +2 more sources
Midodrine treatment for chronic fatigue syndrome [PDF]
Abstract The long term results of midodrine treatment in a patient having debilitating chronic fatigue syndrome (CFS) are reported. Midodrine treatment, directed at the autonomic nervous system, resulted in correction of the dysautonomia followed by improvement of fatigue.
J E Naschitz +3 more
openaire +3 more sources
Impact of Midodrine on Optimization of β-blocker Therapy in Patients with Heart Failure with Reduced Ejection Fraction [PDF]
Introduction: Midodrine, an α-adrenergic agonist approved for orthostatic hypotension, is used off-label for hypotension in patients with heart failure with reduced ejection fraction (HFrEF). However, its prevalence, clinical outcomes, and risks in HFrEF
de Almeida, Kristen +4 more
core +2 more sources
Background Hypotension and bradycardia are common hemodynamic complications following carotid artery stenting in patients with carotid artery stenosis.
Yaser Jenab +2 more
doaj +1 more source
Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
Objective The efficacy and safety of 1‐month atomoxetine and midodrine therapies were compared. Three‐month atomoxetine and combination therapies were investigated for additional benefits.
Jung‐Ick Byun +13 more
doaj +1 more source
Role of Midodrine on Vasopressor Duration in Patients with Sepsis [PDF]
Existing literature evaluating the off-label use of midodrine has focused primarily on postoperative hypotensive patients requiring a single vasopressor.
Belfer, Julie J +3 more
core +2 more sources

